Ajax-Loading

Sino Biopharmaceutical Ltd - Return On Total Capital

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.

The item "Return-On-Total-Capital" stands at 8.52 percent as of 06/30/2025.

As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Return On Total Capital" stands at 8.52 Percent. This represents an increase of 0.08 percentage points compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -1.27 percentage points compared to the value the year prior.
The 1 year change in percentage points is -1.27.
The 3 year change in percentage points is -10.66.

The Serie's long term average value is 12.01 percent. It's latest available value, on 06/30/2025, is 3.49 percentage points lower, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2023, to it's latest available value, on 06/30/2025, is +5.93.
The Serie's change in percentage points from it's maximum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is -31.25.

Return On Total Capital for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Return On Total Capital905,699,262,464.00
LogoJohnson & Johnson - Return On Total Capital486,508,953,600.00
LogoAbbVie Inc - Return On Total Capital399,570,305,024.00
LogoRoche Holding AG - Return On Total Capital317,433,206,677.55
LogoAstraZeneca PLC - Return On Total Capital280,205,508,085.11